Showing results (31-40 of 5,675) with videos related to
Sort By:
Pageof 568
Lancet (London, England)|February 3, 1979
Gamma-aminobutyric-acid deficiency in brain of schizophrenic patientsT L Perry, S J Kish, J Buchanan, et al.Journal of the Neurological Sciences|December 1, 1989
Beta-N-methylamino-L-alanine. Chronic oral administration is not neurotoxic to miceT L Perry, C Bergeron, A J Biro, et al.Neurology|March 1, 1979
Isoniazid therapy of Huntington diseaseT L Perry, J M Wright, S Hansen, et al.Neurology|March 1, 1981
Neurotransmitter amino acids in dominantly inherited cerebellar disordersT L Perry, S J Kish, S Hansen, et al.Journal of Neurochemistry|March 1, 1982
Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's choreaT L Perry, S Hansen, R A Wall, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1992
Excitatory amino acid receptor antagonist in murine motoneuron disease (the wobbler mouse)C Krieger, T L Perry, S Hansen, et al.Neuroscience Letters|October 8, 1986
Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouseT L Perry, V W Yong, K Jones, et al.Neuroscience Letters|September 12, 1986
Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouseT L Perry, V W Yong, R A Wall, et al.Pediatrics|October 1, 1976
Lactic acidosis in three sibs due to defects in both pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexesJ C Haworth, T L Perry, J P Blass, et al.Journal of the Neurological Sciences|October 1, 1990
Brain amino acid contents are dissimilar in sporadic and Guamanian amyotrophic lateral sclerosisT L Perry, C Bergeron, J C Steele, et al.Pageof 568